|
|
|
Volumn 17, Issue 1, 2015, Pages 21-36
|
|
Lipid metabolism and lipodystrophy in HIV-1-infected patients: the role played by nonnucleoside reverse transcriptase inhibitors
a a |
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;
BENZOXAZINE DERIVATIVE;
EFAVIRENZ;
ETRAVIRINE;
HUMAN IMMUNODEFICIENCY VIRUS PROTEINASE INHIBITOR;
LOPINAVIR;
PYRIDAZINE DERIVATIVE;
RITONAVIR;
RNA DIRECTED DNA POLYMERASE INHIBITOR;
CHEMICALLY INDUCED;
DRUG EFFECTS;
DYSLIPIDEMIA;
HIGHLY ACTIVE ANTIRETROVIRAL THERAPY;
HIV-ASSOCIATED LIPODYSTROPHY SYNDROME;
HUMAN;
HYPERCHOLESTEROLEMIA;
HYPERTRIGLYCERIDEMIA;
LIPID METABOLISM;
METABOLISM;
TREATMENT OUTCOME;
ANTI-HIV AGENTS;
ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE;
BENZOXAZINES;
DYSLIPIDEMIAS;
HIV PROTEASE INHIBITORS;
HIV-ASSOCIATED LIPODYSTROPHY SYNDROME;
HUMANS;
HYPERCHOLESTEROLEMIA;
HYPERTRIGLYCERIDEMIA;
LIPID METABOLISM;
LOPINAVIR;
PYRIDAZINES;
REVERSE TRANSCRIPTASE INHIBITORS;
RITONAVIR;
TREATMENT OUTCOME;
|
|
EID: 84946729112
PISSN: None
EISSN: 16986997
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (17)
|
|
References (0)
|